Advanced Daily Photo Protection for Patients with Blemish and Acne-Prone Skin
Acne is one of the most common concerns presenting in clinic, affecting both younger patients and the growing number of adults experiencing hormonal or persistent breakouts. While patients often feel that sun exposure temporarily improves their acne, we know from clinical evidence that UV can intensify inflammation, worsen post-inflammatory pigmentation, and compromise barrier health over time.
Heliocare’s newest innovation, Heliocare 360° Acnimat SPF 50+, has been scientifically developed to support clinical acne pathways – delivering very high-level photoprotection, oil control and anti-blemish benefits in one lightweight formula suitable for daily patient use.
Why Photoprotection Matters in Acne Management
For many acne patients, UV exposure is a hidden aggravating factor. The skin’s exposome – the total sum of environmental stressors like UV, pollution and oxidative damage – plays a recognised role in acne progression.
UV radiation can:
- Trigger inflammation that exacerbates breakouts
- Intensify post-inflammatory hyperpigmentation
- Impair the skin barrier, increasing sensitivity and irritation
Using a full-spectrum sunscreen specifically formulated for blemish-prone patients can significantly support treatment outcomes and improve tolerance to topical and oral therapies.
Introducing Heliocare 360° Acnimat SPF 50+
Developed by Cantabria Labs, global leaders in dermatological photoprotection, Heliocare 360° Acnimat SPF 50+ is a clinically driven sunscreen formulated for oily, blemish-prone and acne-prone skin.
It combines powerful UV defence with targeted actives for managing oil production, supporting texture refinement and reducing the appearance of blemishes – making it an ideal recommendation within acne treatment plans.
Clinically Proven Results
The Science Behind the Formula
ASPA-Fernblock® Technology
The latest evolution in Heliocare’s photoprotection research, ASPA-Fernblock® fuses Fernblock® (Polypodium leucotomos extract) with Aspalathus linearis (Rooibos) -creating a next-generation antioxidant complex that protects against UVA, UVB, visible light, and infrared-A. This innovation not only defends against oxidative stress but also protects Vitamin D receptors, helping the skin maintain its natural vitamin D function.
Mattifying System
Silica-based ingredients absorb excess oil and control shine for up to 12 hours¹, creating a smooth, non-greasy finish ideal for patient compliance throughout the day.
Anti-Blemish System
A combination of Succinic Acid, Niacinamide and Pixalia® helps to:
- Regulate sebum and reduce congestion²
- Minimise redness and inflammation
- Reduce the formation of comedones and blemishes
- Support the prevention of post-acne pigmentation
Texture, Tolerance and Suitability for Clinical Pathways
Heliocare 360° Acnimat SPF 50+ is a light oil-in-water emulsion that absorbs rapidly with an ultra-mattifying finish and no white cast, heaviness or stickiness. It is:
- Dermatologically and ophthalmologically tested
- Water and sweat resistant
- Suitable for sensitive or sensitised skin, including those using prescription acne treatments
This ensures high patient tolerance and ease of daily use.
Nothing Protects Skin Like Heliocare 360°
Heliocare is recognised for its science-led approach to photoprotection, with patented technologies that offer full-spectrum defence and powerful antioxidant protection.
With Heliocare 360° Acnimat SPF 50+, clinics can now offer that same exceptional protection with added oil-control and anti-blemish innovation, specifically for acne-prone patients requiring a mattifying, treatment-supportive SPF.
Complete the form below to learn how HELIOCARE 360° can enhance your patients’ skin health with cutting-edge formulations and scientific research.
References
1 AIYeDerm Clinic and Research. (2024). Evaluation of the short-term mattifying efficacy of a cosmetic photoprotector under dermatological control and instrumental evaluation. Mixed and oily skin (sebum level in cheeks above 150); acne-prone with mild–moderate blemishes; 25 volunteers. Inclusion criteria: Age 18–30 years, men and women.
2 AliyeDerm Clinic & Research, Cantabria Labs. Evaluation of the efficacy and tolerance of a cosmetic photoprotector indicated for subjects with acne prone skin under dermatological supervision and instrumental evaluation. 2024. Participants aged 18–30 years, both sexes; Fitzpatrick phototypes II–V; non-sensitive, mixed and oily skin (sebumeter >150 on cheeks); acne-prone with mild–moderate blemishes.